TrialSafety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia
Trial details
- Registry ID
- NCT05124275
- Phase
- Phase 2
Drug research
Pilocarpine Ophthalmic Topical Cream, Dose 1
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as GLK-301; GLK-302
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of PresbyopiaNCT05124275 | Glaukos Corporation | Phase 2 | Completed | 2022-09-06Actual |
| Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye DiseaseNCT05119920 | Glaukos Corporation | Phase 2 | Completed | 2022-07-27Actual |
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
Trial details
- Registry ID
- NCT05119920
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |